Top Markets
Coin of the day
Avidity Biosciences Inc Avidity Biosciences Inc

Avidity Biosciences Inc

RNAM
株式のランク #2179
Avidity Biosciences, Inc. is at the forefront of developing a novel class of... Avidity Biosciences, Inc. is at the forefront of developing a novel class of oligonucleotide-based therapies, known as Antibody Oligonucleotide Conjugates (AOCs). Utilizing its proprietary AOC platform, the company engineers treatments that strategically merge the targeted delivery capabilities of monoclonal antibodies with the precise action of oligonucleotide-based therapeutics. This innovative method aims to reach cell and tissue types previously inaccessible to treatment, thereby more effectively addressing the fundamental genetic causes of various diseases. The company was established on November 13, 2012, by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick, and its main office is located in San Diego, California.
株価
$71.34
最終同期: 2026-03-03
時価総額
$9.84B
変化(1日)
0.00%
変化(1年)
-
US
取引 Avidity Biosciences Inc (RNAM)

カテゴリー

Avidity Biosciences Inc(RNAM)の株式分割履歴
Avidity Biosciences Inc株(シンボル:RNAM)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 25, 2026に行われました。
Aug 25, 2026より前に購入されたRNAM株は、現在0RNAM株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH